Apotex Corp. announced on May 14, 2018 that it is voluntarily recalling 36 lots of Piperacillin and Tazobactam for injection, USP 3.375 gram/vial and 4.5 gram/vial strengths to the consumer level. The product is manufactured by Hospira, Inc., a Pfizer Company, and distributed by Apotex. TheOriginal Article
You may also like
New alloys for manufacturing freeze-dryers
Navigating the Complexities of Emerging Therapy...
INTERPHEX 2025: Preventing Spills in the Manufacturing...
Agentic AI Growth Predicted, but More Than Half of...
Microsoft and SkyCell Collaborate on Pharma Supply...
Siemens Acquires Dotmatics, Extending AI Software...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.